Low levels of AF‐6 expression was reported in 15% of breast cancer patients and linked to adverse prognosis,19 and the loss of AF‐6 was found to promote pancreatic cancer metastasis by inducing Snail expression,20 suggesting that AF‐6 might be a tumour suppressor. This evidence concerns the gene AFDN and neoplasm.